| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2573925 | Vascular Pharmacology | 2016 | 7 Pages |
Abstract
Coronary artery disease (CAD) and its complications remain the most common cause of death worldwide. Cardiac troponins (cTn) are standard biomarkers used today for diagnosis and risk stratification of myocardial infarction (MI). Increasing efforts are made to develop additional, new biomarkers for more effective and safe rule-in and rule-out of MI patients at the emergency department. During the past decade, microRNAs (miRNAs) have emerged as new, potential diagnostic biomarkers in several diseases, including MI. In this review, we aimed to summarize some of the prominent studies in the field, and discuss the potential value of miRNAs in the diagnosis of MI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Fredrik Ahlin, John Arfvidsson, Kris G. Vargas, Stefan Stojkovic, Kurt Huber, Johann Wojta,